Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
Conditions: Liver Transplant Interventions: Drug: CMV-MVA Triplex; Drug: Placebo for CMV-MVA Triplex Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy | Allergy & Immunology | Cytomegalovirus | Infectious Diseases | Liver | Liver Transplant | Research | Transplant Surgery | Transplants | Urology & Nephrology | Vaccines